Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Robert B. Jones currently holds 643,555 shares of ACURA PHARMACEUTICALS, INC (ACUR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert B. Jones has been a net buyer of ACUR stock. They have purchased $49.7K and sold $0 worth of shares.
Robert B. Jones's most recent insider trade was on Nov 20, 2023, when they sold 40,000 shares at $0.00 per share.
Robert B. Jones serves as Executive at ACURA PHARMACEUTICALS, INC (ACUR). They have executed 18 insider transactions totaling $49.7K over their tenure at the company.
Robert B. Jones holds the position of Executive at ACURA PHARMACEUTICALS, INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
Robert B. Jones has shown a buying trading pattern, with $49.7K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Robert B. Jones was on Dec 14, 2017, when they purchased $40.0K worth of ACUR shares. This transaction involved 400,000 shares at $0.10 per share.
Robert B. Jones currently owns 643,555 shares of ACURA PHARMACEUTICALS, INC (ACUR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Robert B. Jones's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Robert B. Jones has 18 Form 4 filings on record as an insider at ACURA PHARMACEUTICALS, INC.
Set alerts for Robert B. Jones and 40,000+ other insiders.